Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FZQ04
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,679
Award facts
- Contract value 100% obligated
- $5,678.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/ml auto-injector medication. The award, valued at $5,678.70, was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role as a critical pharmaceutical supplier to the Department of Defense, fulfilling immediate medical supply requirements for federal healthcare facilities.
This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The underlying IDC, established under the SPE2DB program, authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military health facilities nationwide and internationally. DMS Pharmaceutical Group's continued engagement in supplying specialty medications and auto-injectors, such as Nucala for respiratory and immunological treatments, underscores the company's established position within the federal pharmaceutical supply chain and its capability to provide rapid delivery of critical medications to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FZQ04?
SPE2DB25FZQ04 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FZQ04 worth?
The government has obligated $5,679 on SPE2DB25FZQ04.
Is contract SPE2DB25FZQ04 an order under another contract?
Yes. SPE2DB25FZQ04 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB25FZQ04 competed?
The extent of competition for SPE2DB25FZQ04 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award